Know when to get help and when to pause

What the older studies reported

A 1999 review of mostly child studies named brief face redness and pain at the injection spot as the most often reported unwanted effects.

Those reports do not tell us how often people have these problems with medicine made to order now.

In September 2026, there is no current sermorelin prescribing information that the US drug regulator has reviewed. The regulator is the Food and Drug Administration (FDA). Prescribing information means official drug information for prescribers, beyond the directions on a bottle.

So there is no current FDA-reviewed list of who must avoid it or how often problems happen.

As of September 2026, there is also no FDA-reviewed information on what today’s pharmacy-made sermorelin does during pregnancy.

Discuss pregnancy or plans for pregnancy with the prescriber.

Ask about concerns from related medicines

Growth hormone is a chemical message the body makes. It helps children grow.

In reviews of related hormone-releasing medicines in 2024, FDA discussed possible risks from raised growth hormone levels, including higher blood sugar and fluid build-up.

Those reviews were not an FDA assessment of sermorelin for adult use.

Ask which concerns apply to the medicine you are being offered and your health history. Ask what the follow-up plan would watch for.

Storage needs differ by medicine; the exact product’s label and pharmacy instructions matter.

Pause an offer that skips the checks

Federal law is broken when prescription medicine is dispensed without a valid prescription, as checked in September 2026.

As of September 2026, claiming FDA approval for sermorelin made to order is false.

FDA warnings checked in September 2026 told sellers that wording such as “for research use only” does not let them sell chemicals for human treatment.

Do not let an unanswered doctor or pharmacy check disappear behind a discount. Return to the public records and ask for the missing answer.